News Sentiment

VANI sentiment intelligence

Vivani Medical Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 58 Balanced news tone 55 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 1.36 Week of 10 Jul 2026
Weighted tone 58/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

78/100 classification confidence.

Company focus 47

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

+7.9% over one week, +23.6% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Vivani Medical Insider Bought Shares Worth $999,999, According to a Recent SEC Filing

Market Reaction

Price moving ahead of tone

67/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 78/100 classification
One-week reaction 7.9% Price confirming higher
Trend fit Trend inactive 23.6% over four weeks
Fair value 6.6% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 22
Neutral 30
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 47
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 10
Stock Titan 6
MarketBeat 3
GlobeNewswire 3
Investing.com 3
Moomoo 3
TradingView 3
simplywall.st 3

Event Lens

What the news is about

Classified themes
Market update 26
Deals and strategy 9
Earnings 9
Analyst action 6
Balance sheet 2
Regulatory and legal 2
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-55 of 55
MassDevice Direct company coverage

Vivani to sell neurotech subsidiary Cortigent to ClearOne

Vivani Medical announced a definitive agreement to sell its neurotech subsidiary, Cortigent, to ClearOne. The transaction will result in ClearOne being renamed "Cortigent Holdings, Inc." and trading under the Nasdaq ticker "CRGT," with Vivani retaining a majority stake. This move

Tone
Positive 72/100
Event
Deals and strategy
Published
02 Jul 2026 15:41
Source
MassDevice
Business Wire Direct company coverage

ClearOne Announces Entry into Merger Agreement with Cortigent, Inc., a Wholly-Owned Subsidiary of Vivani Medical

ClearOne, Inc. has entered into a definitive merger agreement with Cortigent, Inc., a wholly-owned subsidiary of Vivani Medical. As part of the transaction, Cortigent will become a wholly-owned subsidiary of ClearOne, and ClearOne will conduct a financing round to raise $10 milli

Tone
Positive 66/100
Event
Deals and strategy
Published
02 Jul 2026 11:41
Source
Business Wire
TradingView Direct company coverage

Price to earnings forward of Vivani Medical, Inc. – NASDAQ:VANI

This article provides a financial overview of Vivani Medical, Inc. (NASDAQ: VANI), specifically focusing on its forward price-to-earnings ratio. It indicates that the market was closed at the time of the report and there were no trades. The article is primarily a data page from T

Tone
Neutral 50/100
Event
Earnings
Published
01 Jul 2026 07:39
Source
TradingView
Stock Titan Direct company coverage

Vivani Medical (NASDAQ: VANI) wins HREC nod for SLIM-1 semaglutide implant trial

Vivani Medical has received approval from Bellberry, an Australian human research ethics committee, to begin its SLIM-1 Phase 1 clinical trial for NPM-139, a semaglutide implant aimed at obesity and chronic weight management. The trial will assess the safety, tolerability, and ph

Tone
Positive 67/100
Event
Regulatory and legal
Published
30 Jun 2026 20:10
Source
Stock Titan
TradingView Direct company coverage

Enterprise value to EBIT forward of Vivani Medical Inc. – DUS:U5P

The article focuses solely on the enterprise value to EBIT forward for Vivani Medical Inc. (DUS:U5P). It provides no specific financial figures but presents the topic as a data point for the company listed on the Dusseldorf Stock Exchange. The content is primarily a header and na

Tone
Neutral 50/100
Event
Market update
Published
27 Jun 2026 18:09
Source
TradingView
GlobeNewswire Direct company coverage

Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr. Dean Baker

Vivani Medical, Inc. (NASDAQ: VANI) has announced the appointment of August Moretti to its board of directors, where he will chair the Audit Committee and serve on the Compensation Committee. Concurrently, Dr. Dean Baker has retired from the board after a distinguished tenure. Th

Tone
Positive 71/100
Event
Market update
Published
27 Jun 2026 07:09
Source
GlobeNewswire